Stroke Decisions Made Smarter
Forest Devices is developing ALPHASTROKE,
the first stroke screening device designed for use by medical personnel in any environment.
Of the 800K strokes in the United States, 400K will result in patients going to the wrong hospital. A significant reason for this is the lack of objective tools to screen/identify victims.
The process of transporting a patient from a non-Stroke Center to a Stroke Center Hospital delays the appropriate life saving treatment for approximately 110 minutes. This added time significantly increases the chance of complications, death and disability.
The inability to screen for stroke leads to the healthcare industry spending an additional $20 billion per year in transportation, hospitalization, and long term care.
How ALPHASTROKE Works
By increasing the number of stroke victims who receive early treatment, ALPHASTROKE could dramatically improve patient outcomes. Early treatment can prevent up to 6,000 deaths and 300,000 hospital days per year, as well as enabling tens of thousands of patients to walk without assistance and avoid dependence on assisted living facilities or nursing homes.